Table of Content

1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Proteomics Market
4. Executive Summary
5. Voice of Customer
5.1. Brand Awareness & Brand Recall
5.2. Factors Influencing Purchase Decision
5.3. Unmet Needs & Challenges
6. Global Proteomics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Application (Clinical Diagnostic, Drug Discovery, Diagnostic Biomarker Discovery, Others)
6.2.2. By Indication (Oncology, Infectious Disease, Respiratory, Cardiology, Others)
6.2.3. By Technology
6.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
6.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
6.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
6.2.3.4. High-throughput (X-ray crystallography, NMR)
6.2.3.5. Bioinformatic analysis
6.2.4. By Type (Expression, Functional, Structural, Computational)
6.2.5. By Product (Reagents and Assays, Instruments, Software & Services)
6.2.6. By End-User (Pharmaceutical and Biotechnology Companies, Research Institutes, CROs)
6.2.7. By Company (2020)
6.2.8. By Region
6.3. Product Market Map
7. North America Proteomics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Application
7.2.2. By Indication
7.2.3. By Technology
7.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
7.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
7.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
7.2.3.4. High-throughput (X-ray crystallography, NMR)
7.2.3.5. Bioinformatic analysis
7.2.4. By Type
7.2.5. By Product
7.2.6. By End-User
7.2.7. By Country
7.3. North America: Country Analysis
7.3.1. United States Proteomics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Application
7.3.1.2.2. By Indication
7.3.1.2.3. By Technology
7.3.1.2.4. By Type
7.3.1.2.5. By Product
7.3.1.2.6. By End-User
7.3.2. Canada Proteomics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Application
7.3.2.2.2. By Indication
7.3.2.2.3. By Technology
7.3.2.2.4. By Type
7.3.2.2.5. By Product
7.3.2.2.6. By End-User
7.3.3. Mexico Proteomics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Application
7.3.3.2.2. By Indication
7.3.3.2.3. By Technology
7.3.3.2.4. By Type
7.3.3.2.5. By Product
7.3.3.2.6. By End-User
8. Europe Proteomics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Application
8.2.2. By Indication
8.2.3. By Technology
8.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
8.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
8.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
8.2.3.4. High-throughput (X-ray crystallography, NMR)
8.2.3.5. Bioinformatic analysis
8.2.4. By Type
8.2.5. By Product
8.2.6. By End-User
8.2.7. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Proteomics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Application
8.3.1.2.2. By Indication
8.3.1.2.3. By Technology
8.3.1.2.4. By Type
8.3.1.2.5. By Product
8.3.1.2.6. By End-User
8.3.2. United Kingdom Proteomics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Application
8.3.2.2.2. By Indication
8.3.2.2.3. By Technology
8.3.2.2.4. By Type
8.3.2.2.5. By Product
8.3.2.2.6. By End-User
8.3.3. France Proteomics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Application
8.3.3.2.2. By Indication
8.3.3.2.3. By Technology
8.3.3.2.4. By Type
8.3.3.2.5. By Product
8.3.3.2.6. By End-User
8.3.4. Italy Proteomics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Application
8.3.4.2.2. By Indication
8.3.4.2.3. By Technology
8.3.4.2.4. By Type
8.3.4.2.5. By Product
8.3.4.2.6. By End-User
8.3.5. Spain Proteomics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Application
8.3.5.2.2. By Indication
8.3.5.2.3. By Technology
8.3.5.2.4. By Type
8.3.5.2.5. By Product
8.3.5.2.6. By End-User
9. Asia-Pacific Proteomics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Application
9.2.2. By Indication
9.2.3. By Technology
9.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
9.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
9.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
9.2.3.4. High-throughput (X-ray crystallography, NMR)
9.2.3.5. Bioinformatic analysis
9.2.4. By Type
9.2.5. By Product
9.2.6. By End-User
9.2.7. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. Japan Proteomics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Application
9.3.1.2.2. By Indication
9.3.1.2.3. By Technology
9.3.1.2.4. By Type
9.3.1.2.5. By Product
9.3.1.2.6. By End-User
9.3.2. China Proteomics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Application
9.3.2.2.2. By Indication
9.3.2.2.3. By Technology
9.3.2.2.4. By Type
9.3.2.2.5. By Product
9.3.2.2.6. By End-User
9.3.3. India Proteomics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Application
9.3.3.2.2. By Indication
9.3.3.2.3. By Technology
9.3.3.2.4. By Type
9.3.3.2.5. By Product
9.3.3.2.6. By End-User
9.3.4. South Korea Proteomics Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Application
9.3.4.2.2. By Indication
9.3.4.2.3. By Technology
9.3.4.2.4. By Type
9.3.4.2.5. By Product
9.3.4.2.6. By End-User
9.3.5. Australia Proteomics Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Application
9.3.5.2.2. By Indication
9.3.5.2.3. By Technology
9.3.5.2.4. By Type
9.3.5.2.5. By Product
9.3.5.2.6. By End-User
10. South America Proteomics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Application
10.2.2. By Indication
10.2.3. By Technology
10.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
10.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
10.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
10.2.3.4. High-throughput (X-ray crystallography, NMR)
10.2.3.5. Bioinformatic analysis
10.2.4. By Type
10.2.5. By Product
10.2.6. By End-User
10.2.7. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Proteomics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Application
10.3.1.2.2. By Indication
10.3.1.2.3. By Technology
10.3.1.2.4. By Type
10.3.1.2.5. By Product
10.3.1.2.6. By End-User
10.3.2. Argentina Proteomics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Application
10.3.2.2.2. By Indication
10.3.2.2.3. By Technology
10.3.2.2.4. By Type
10.3.2.2.5. By Product
10.3.2.2.6. By End-User
10.3.3. Colombia Proteomics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Application
10.3.3.2.2. By Indication
10.3.3.2.3. By Technology
10.3.3.2.4. By Type
10.3.3.2.5. By Product
10.3.3.2.6. By End-User
11. Middle East & Africa Proteomics Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Application
11.2.2. By Indication
11.2.3. By Technology
11.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
11.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
11.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
11.2.3.4. High-throughput (X-ray crystallography, NMR)
11.2.3.5. Bioinformatic analysis
11.2.4. By Type
11.2.5. By Product
11.2.6. By End-User
11.2.7. By Country
11.3. Middle East & Africa: Country Analysis
11.3.1. South Africa Proteomics Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Application
11.3.1.2.2. By Indication
11.3.1.2.3. By Technology
11.3.1.2.4. By Type
11.3.1.2.5. By Product
11.3.1.2.6. By End-User
11.3.2. Saudi Arabia Proteomics Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Application
11.3.2.2.2. By Indication
11.3.2.2.3. By Technology
11.3.2.2.4. By Type
11.3.2.2.5. By Product
11.3.2.2.6. By End-User
11.3.3. UAE Proteomics Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Application
11.3.3.2.2. By Indication
11.3.3.2.3. By Technology
11.3.3.2.4. By Type
11.3.3.2.5. By Product
11.3.3.2.6. By End-User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Competition Outlook
14.2. Players Profiled (Leading Companies)
14.2.1. Thermo Fisher Scientific, Inc.
14.2.2. Agilent Technologies, Inc.
14.2.3. Waters Corporation
14.2.4. Bio-Rad Laboratories, Inc.
14.2.5. Danaher Corporation (SCIEX)
14.2.6. GE Healthcare, Inc.
14.2.7. PerkinElmer, Inc.
14.2.8. Becton, Dickinson and Company
14.2.9. Illumina, Inc.
14.2.10. Biocon Limited
14.2.11. Qiagen N.V.
14.2.12. Bruker Corporation
14.2.13. Luminex Corporation
14.2.14. Evotec SE
14.2.15. Horiba, Ltd.
14.2.16. Creative Proteomics
14.2.17. Promega Corporation
14.2.18. CellCarta Precision Medicine, Inc.
14.2.19. Bioproximity LLC
14.2.20. Applied Biomics, Inc.
15. Strategic Recommendations
16. About Us & Disclaimer